Replies to post #1888 on Inovio Pharmaceuticals Inc (INO)

[kris_kade]

Dr. KIm buying today means squat, IMHO. He squandered the good will with his below market secondary recently.

Also newbies do not know the history of INO nor the fact that it's typical for such penny biotechs to reverse-split only to screw the current shareholders.

While I have not sold my position (not significant though), I will wait for the reverse split to add more.

[mariorx]

I've been long for quite a while I came out positive 0.05 on 100k shares but I have to be honest I've lost my faith in Joseph. I'm not holding anymore. Ill see where it goes from here and invest again after positive results.

[LeoBobcat]

Everywhereman,

Can you elaborate on what you mean by the negotiation for the partnership with big pharma is one of the major reasons for the last dilution? I don't follow...

Also, any thoughts on why it is taking so long for a deal with big pharma to be negotiated? Dr. Kim is on record last September stating that he hoped to have a deal by the end of 2012 and that never materialized. It seems that if there were truly a high interest in INO then something would have happened already.

Finally, I realize that you hold Dr. Kim in high regard and he is a brilliant man but there is more to this story. Dr. Kim reminds me of the Chesshire cat in his interviews. My gut instinct tells me that he has evidence that INO has a disruptive technology that could potentially change the way we treat disease forever.

Thanks.

[thomaswalsh]

Excellent, informative post. My comments on Hep C trial were definitely misguided. My point was, INO needed the data to be conclusive to get the ball rolling sort of speak. yes Chrontech owns the Hep C IP, but INO was joint venture thus joint risk.


Again, thanks for the info!